Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FUB-181 shown to improve learning and memory in mice

July 2, 1998

Angiotech initiates phase I study of paclitaxel for the treatment of multiple sclerosis

July 1, 1998

Spotlight on 5-HT1B/1D agonists for migraine

July 1, 1998

Glutamate transport blockers discovered using novel system developed at Suntory

July 1, 1998

Zaleplon shows advantage over zolpidem for sleep disorders in phase III

June 30, 1998

Biovail granted license to Celgene's ADHD treatment

June 29, 1998

CoCensys initiates phase II migraine study with ganaxolone tablets

June 29, 1998

Quadramet approved in Canada

June 26, 1998

HMR withdraws cerebral metabolic enhancer from Japanese market; development in AD continues

June 26, 1998

Cathepsin B and L inhibitors claimed by Canadian researchers

June 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...